Avian influenza a(H5N1) virus in Egypt

Emerging Infectious Diseases

Volumn 22, Issue 3, 2016, Pages 379-388

  Kayali, Ghazi ^a   Kandeil, Ahmed ^b   El Shesheny, Rabeh ^b   Kayed, Ahmed S ^b   Maatouq, Asmaa M ^b   Cai, Zhipeng ^c   McKenzie, Pamela P ^a   Webby, Richard J ^a   Refaey, Samir El ^d   Kandeel, Amr ^d   Ali, Mohamed A ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c GEORGIA STATE UNIVERSITY   (United States)

^d MINISTRY OF HEALTH   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; SIALIDASE;

ANTIGENICITY; ARTICLE; AVIAN INFLUENZA (H5N1); CROSS REACTION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EGYPT; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; INFLUENZA A VIRUS (H9N2); NONHUMAN; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; EPIDEMIOLOGICAL MONITORING; GENETICS; INFLUENZA A VIRUS (H5N1); INFLUENZA IN BIRDS; INFLUENZA, HUMAN; POULTRY; POULTRY DISEASES; VETERINARY; VIROLOGY;

ANIMALS; EGYPT; EPIDEMIOLOGICAL MONITORING; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; POULTRY; POULTRY DISEASES;

EID: 84958739757     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2203.150593     Document Type: Article

References (27)

1. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2015 [cited 2015 Apr 15]. http://www.who.int/influenza/human_animal_interface/EN_GIP_20150303cumulativeNumber H5N1cases.pdf?ua=1.
2. Aly MM, Arafa A, Hassan MK. Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Dis. 2008;52:269-77. http://dx.doi.org/10.1637/8166-103007-Reg.1.
3. Peyre M, Samaha H, Makonnen YJ, Saad A, Abd-Elnabi A, Galal S, et al. Avian influenza vaccination in Egypt: limitations of the current strategy. J Mol Genet Med. 2009;3:198-204.
4. Kayali G, Webby RJ, Ducatez MF, El Shesheny RA, Kandeil AM, Govorkova EA, et al. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One. 2011;6:e17730. http://dx.doi.org/10.1371/journal.pone.0017730.
5. El-Shesheny R, Kandeil A, Bagato O, Maatouq AM, Moatasim Y, Rubrum A, et al. Molecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade. J Gen Virol. 2014;95:1444-63. http://dx.doi.org/10.1099/ vir.0.063495-0.
6. Kayali G, Kandeil A, El-Shesheny R, Kayed AS, Gomaa MM, Maatouq AM, et al. Active surveillance for avian influenza virus, Egypt, 2010-2012. Emerg Infect Dis. 2014;20:542-51. http://dx.doi.org/10.3201/eid2004.131295.
7. Arafa A, Suarez D, Kholosy SG, Hassan MK, Nasef S, Selim A, et al. Evolution of highly pathogenic avian influenza H5N1 viruses in Egypt indicating progressive adaptation. Arch Virol. 2012;157:1931-47. http://dx.doi.org/10.1007/00705-012-1385-9.
8. Cattoli G, Fusaro A, Monne I, Coven F, Joannis T, El-Hamid HSA, et al. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine. 2011;29:9368-75. http://dx.doi.org/10.1016/j.vaccine.2011.09.127.
9. El-Shesheny R, Kayali G, Kandeil A, Cai Z, Barakat AB, Ghanim H, et al. Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011. J Gen Virol. 2012;93:2564-74. http://dx.doi.org/10.1099/vir.0.043299-0.
10. Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Daidoji T, Takagi T, et al. Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt. J Gen Virol. 2012;93:2215-26. http://dx.doi.org/10.1099/vir.0.044032-0.
11. Younan M, Poh MK, Elassal E, Davis T, Rivailler P, Balish AL, et al. Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011. Emerg Infect Dis. 2013;19:43-50. http://dx.doi.org/10.3201/eid1901.121080.
12. Dudley JP. Age-specific infection and death rates for human A(H5N1) avian influenza in Egypt. Euro Surveill. 2009;14:19198.
13. Kayali G, El-Shesheny R, Kutkat MA, Kandeil AM, Mostafa A, Ducatez MF, et al. Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg Infect Dis. 2011;17:2306-8. http://dx.doi.org/10.3201/eid1712.110683.
14. Arafa AS, Hagag N, Erfan A, Mady W, El-Husseiny M, Adel A, et al. Complete genome characterization of avian influenza virus subtype H9N2 from a commercial quail flock in Egypt. Virus Genes. 2012;45:283-94. http://dx.doi.org/10.1007/s11262-012-0775-0.
15. Monne I, Hussein HA, Fusaro A, Valastro V, Hamoud MM, Khalefa RA, et al. H9N2 influenza A virus circulates in H5N1 endemically infected poultry population in Egypt. Influenza Other Respir Viruses. 2013;7:240-3. http://dx.doi.org/10.1111/j.1750-2659.2012.00399.x.
16. Smith GJ, Donis RO; World Health Organization/World Organization for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses. 2015;9:271-6. http://dx.doi.org/10.1111/irv.12324.
17. Kandeil A, El-Shesheny R, Maatouq AM, Moatasim Y, Shehata MM, Bagato O, et al. Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013. Arch Virol. 2014;159:2861-76. http://dx.doi.org/10.1007/s00705-014-2118-z.
18. Gomaa MR, Kayed AS, Elabd MA, Zeid DA, Zaki SA, El Rifay AS, et al. Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study. J Infect Dis. 2015;211:1399-407. http://dx.doi.org/10.1093/infdis/jiu529.
19. Clegg CH, Roque R, Van Hoeven N, Perrone L, Baldwin SL, Rininger JA, et al. Adjuvant solution for pandemic influenza vaccine production. Proc Natl Acad Sci USA. 2012;109:17585-90. http://dx.doi.org/10.1073/pnas.1207308109.
20. Nolan TM, Richmond PC, Skeljo MV, Pearce G, Hartel G, Formica NT, et al. Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated splitvirus influenza A (H5N1) vaccine in healthy adults. Vaccine. 2008;26:4160-7. http://dx.doi.org/10.1016/j.vaccine.2008.05.077.
21. Juno J, Fowke KR, Keynan Y. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol. 2012;2012:797180. http://dx.doi.org/10.1155/2012/797180.
22. Horby P, Sudoyo H, Viprakasit V, Fox A, Thai PQ, Yu H, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010;138:1550-8. http://dx.doi.org/10.1017/S0950268810000518.
23. Tian G, Zeng X, Li Y, Shi J, Chen H. Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam. Avian Dis. 2010;54(Suppl):287-9. http://dx.doi.org/10.1637/8707-031709-ResNote.1.
24. Chen H. Avian influenza vaccination: the experience in China. Rev Sci Tech. 2009;28:267-74.
25. Kapczynski DR, Pantin-Jackwood M, Guzman SG, Ricardez Y, Spackman E, Bertran K, et al. Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection. J Virol. 2013;87:9086-96. http://dx.doi.org/10.1128/ JVI.00666-13.
26. Swayne DE. Recommendations from the avian influenza vaccine workshop. Ann N Y Acad Sci. 2006;1081:226-7. http://dx.doi.org/10.1196/annals.1373.008.
27. WHO/OIE/FAO H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses. 2012;6:5. http://dx.doi.org/10.1111/j.1750-2659.2011.00298.x.